Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
RecruitingPhase 1Healthy volunteers welcome
Who can join
Ages 18 to 55 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * at least one lifetime exposure to cannabis * good physical and mental health Exclusion Criteria: * cannabis naive individuals * major current or recent stressors * taking estrogen supplements or oral contraceptive pills (for women)
About the study
The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.
What is being tested
- THC (drug)
- Placebo (drug)
Sponsor: Yale University · Participants: 100 · Started: 2015-06
Contact the study team
- Christina Luddy, BS · Phone: 203-932-5711
Official record on ClinicalTrials.gov — NCT02781519
Locations in the U.S.
| Connecticut | Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.